⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL697887 | 1.00 | — | — | |
| SCHEMBL697886 | 1.00 | — | — | |
| SCHEMBL28147592 | 0.97 | ADH1B (0.46) | — | |
| Hydrochloric Acid SCHEMBL28009514 | 0.97 | — | — | |
| SCHEMBL4229324 | 0.97 | — | — | |
| SCHEMBL4229332 | 0.97 | — | — | |
| Benzene SCHEMBL28325661 | 0.95 | ADH1B (0.43) | — | |
| Alanine SCHEMBL23044934 | 0.91 | ADH1B (0.40) | — | |
| Nitrous Acid SCHEMBL8342017 | 0.91 | ADH1B (0.40) | — | |
| Nitrous Acid SCHEMBL8342021 | 0.91 | ADH1B (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105611946-B | Polymers suitable for cell culture | 天主教大学基金会 | 2019-07-16 | — | — | CN | disclosed |
| CN-108137483-A | The synthesis of Laevomethanone Hydrochloride or the right methadone of hydrochloric acid and its application method | 科迪实验室公司 | 2018-06-08 | — | — | CN | disclosed |
| EP-2948452-B1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2017-08-09 | — | — | EP | disclosed |
| US-9708330-B2 | 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-07-18 | — | — | US | disclosed |
| US-9708330-B2 | 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-07-18 | — | — | US | disclosed |
| US-9708330-B2 | 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-07-18 | — | — | US | disclosed |
| US-20150361082-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1-H)-ONE BASED IPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-12-17 | — | — | US | disclosed |
| US-20150361082-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1-H)-ONE BASED IPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-12-17 | — | — | US | disclosed |
| US-20150361082-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1-H)-ONE BASED IPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-12-17 | — | — | US | disclosed |
| EP-2948452-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2015-12-02 | — | — | EP | disclosed |
| US-20140213599-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2014-07-31 | — | — | US | disclosed |
| CN-102753533-B | Imidazolidinedione derivatives | AUTIFONY THERAPEUTICS LTD | 2014-07-30 | — | — | CN | disclosed |
| US-20130095562-A1 | OIL RELEASE WITH AMINO ACID-BASED COMPOUNDS HAVING A LONG CHAIN N-ACYL GROUP | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-18 | — | — | US | disclosed |
| US-20130079259-A1 | OIL RELEASE WITH POLYETHYLENE OXIDE SEGMENT-CONTAINING N-LAUROYL AMINO ACID-BASED COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-28 | — | — | US | disclosed |
| US-20100152099-A1 | MACROCYCLIC COMPOUNDS FOR INHIBITION OF TUMOR NECROSIS FACTOR ALPHA | ENSEMBLE THERAPEUTICS CORPORATION | 2010-06-17 | — | — | US | disclosed |
| WO-2010022249-A2 | MACROCYCLIC COMPOUNDS FOR INHIBITION OF TUMOR NECROSIS FACTOR ALPHA | ENSEMBLE DISCOVERY CORPORATION (US) | 2010-02-25 | — | — | WO | disclosed |
| CN-101227885-A | Wrinkle preventing/improving agent | SHISEIDO CO LTD (JP) | 2008-07-23 | — | — | CN | disclosed |
| EP-0187500-B1 | MONOBACTAMS | THE UPJOHN COMPANY (US) | 1993-04-28 | — | — | EP | disclosed |
| US-4883869-A | BACTERICIDES, ANTIBIOTICS | THE UPJOHN COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| US-4742048-A | Tetrapeptides and pentapeptides, their preparation and compositions containing them | RHONE-POULENC INDUSTRIES (FR) | 1988-05-03 | — | — | US | disclosed |